ArticleJournal of cancer research and clinical oncology2018

Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.

Yunan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.